|
|
This model has been developed by the hepatology unit of the CHRU Lille with the collaboration of 4 other French centers. |
|
* « In patients who have been treated with albumin infusions, in order to avoid the use of an artificial value, it is recommended to use the available albumin value before infusion of albumin » |
|
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. Hepatology. 2007 Jun;45(6):1348-54.
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP,Hayes PC, Murray LS, Morris AJ. Department of Gastroenterology, Glasgow Royal Infirmary, Castle St, Glasgow G4 0SF, UK. Ewan.Forrest@northglasgow.scot.nhs.uk. Gut. 2005 Aug;54(8):1174-9.
A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R,Arroyo V, Caballería J, Ginès P, Bataller R. Liver Unit, Institut Clínic Malalties Digestives i Metabòliques, Hospital Clinic, and Centro de Investigación Biomédica Esther Koplowitz, Barcelona, Catalonia, Spain. Am J Gastroenterol. 2008 Nov;103(11):2747-56. Epub 2008 Aug 21.
|